LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Novel Method Introduced for Dry Storage of Biological Samples

By LabMedica International staff writers
Posted on 12 Mar 2018
Print article
Image: An illustration of the novel method for transporting biospecimens, which eliminates the current method using cold-chain transport (Photo courtesy of Washington University).
Image: An illustration of the novel method for transporting biospecimens, which eliminates the current method using cold-chain transport (Photo courtesy of Washington University).
A novel method for preserving biological samples collected for diagnostic testing at room temperature may one day eliminate the need for refrigeration, which is often not available in third-world settings.

Investigators at Washington University (St. Louis, MO, USA) have introduced a universal biospecimen preservation approach based on nanoporous material encapsulation for preserving protein biomarkers in biofluids under normal (nonrefrigerated) storage conditions. The protein biomarkers in the relevant biofluids such as blood, urine, serum, and plasma are first encapsulated within nanoporous zeolitic imidazolate framework-8 (ZIF-8) crystals and then dried on paper substrates via a dry spot sample collection method. Zeolitic imidazolate frameworks (ZIFs) are a class of metal-organic frameworks composed of tetrahedrally coordinated transition metal ions (e.g. Fe, Co, Cu, Zn) connected by imidazolate linkers.

To test the dry storage method, the investigators used artificial urine samples spiked with neutrophil gelatinase-associated lipcalin (NGAL), a biomarker for acute kidney injury; and blood samples spiked with CA-125, a biomarker for ovarian cancer. The samples were mixed with precursors of the nanoporous material ZIF-8 and then dried on paper at room temperature.

Results revealed that urine samples stored dry at room temperature retained more than 90% of NGAL. Control samples without ZIF-8 encapsulation had less than 30% of NGAL preserved. Blood samples spiked with CA-125 and encapsulated by ZIF-8 showed about 85% preservation, while those without the encapsulation showed 50% or less preservation. Overall, results obtained with samples stored dry at temperatures up to 40 degrees Celsius showed preservation efficacy comparable to those maintained by the refrigeration method (freezing liquid samples at −20 degrees Celsius).

"One of our next steps is to take the technology out of the laboratory and commercialize it so that it can work to the greatest good for the greatest number of people," said contributing author Dr. Evan D. Kharasch, professor of biochemistry and molecular biophysics at Washington University. "This would make it widely available in both first-world countries as well as emerging countries and in emergency situations or environmental disasters where we need to deploy people and have scarce resources."

The dry storage protocol was described in detail in the February 1, 2018, online edition of the journal Chemistry of Materials.

Related Links:
Washington University

Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Respiratory Bacterial Panel
Real Respiratory Bacterial Panel 2
New
cTnI/CK-MB/Myo Test
Finecare cTnI/CK-MB/Myo Rapid Quantitative Test

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.